The expression of PD-L1 in HCC primarily on infiltrating ICs rather than tumor cells suggests that tumors may evade immune surveillance primarily by manipulation of PD-L1+ ICs, e.g., cytotoxic T lymphocytes. The gene discussed is CD274; the disease is neoplasm.